Correlation Between AptaBio Therapeutics and Kia Corp

Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Kia Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Kia Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AptaBio Therapeutics and Kia Corp, you can compare the effects of market volatilities on AptaBio Therapeutics and Kia Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Kia Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Kia Corp.

Diversification Opportunities for AptaBio Therapeutics and Kia Corp

-0.21

Correlation Coefficient

AptaBio Therapeutics  Kia Corp

Very good diversification

The 3 months correlation between AptaBio and Kia is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Kia Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kia Corp and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Kia Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kia Corp has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Kia Corp go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Kia Corp

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Kia Corp. In addition to that, AptaBio Therapeutics is 1.52 times more volatile than Kia Corp. It trades about -0.04 of its total potential returns per unit of risk. Kia Corp is currently generating about 0.09 per unit of volatility. If you would invest  9,090,000  in Kia Corp on October 24, 2024 and sell it today you would earn a total of  1,010,000  from holding Kia Corp or generate 11.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

AptaBio Therapeutics  vs.  Kia Corp

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kia Corp

Risk-Adjusted Performance

7 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Kia Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kia Corp may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with AptaBio Therapeutics and Kia Corp

The main advantage of trading using opposite AptaBio Therapeutics and Kia Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Kia Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kia Corp will offset losses from the drop in Kia Corp's long position.

The idea behind AptaBio Therapeutics and Kia Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.